Elite Pharmaceuticals Inc. (OTCMKTS:ELTP - Get Free Report) shares gapped up prior to trading on Friday . The stock had previously closed at $0.67, but opened at $0.70. Elite Pharmaceuticals shares last traded at $0.72, with a volume of 860,448 shares trading hands.
Elite Pharmaceuticals Price Performance
The company has a market capitalization of $801.27 million, a PE ratio of -37.50 and a beta of 0.17. The company has a current ratio of 3.27, a quick ratio of 1.90 and a debt-to-equity ratio of 0.12. The company's 50 day moving average price is $0.51 and its 200-day moving average price is $0.50.
About Elite Pharmaceuticals
(
Get Free Report)
Elite Pharmaceuticals, Inc, a specialty pharmaceutical company, engages in the development, manufacture, and sale of oral, controlled-release products, and generic pharmaceuticals. The company operates in two segments, Abbreviated New Drug Applications for Generic Pharmaceuticals and New Drug Applications for Branded Pharmaceuticals.
Further Reading
Before you consider Elite Pharmaceuticals, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Elite Pharmaceuticals wasn't on the list.
While Elite Pharmaceuticals currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
